Merck (NYSE:MRK), known as MSD outside the United States and Canada,
announced the successful completion of the tender offer for all of the
outstanding shares of common stock of Idenix Pharmaceuticals, Inc.
(NASDAQ:IDIX) at a purchase price of $24.50 per share.
Fourth quarter operating results from continuing operations include:
CHELMSFORD, Mass., August 5, 2014 (GLOBE NEWSWIRE) -- Mercury Systems, Inc. (Nasdaq:MRCY) ( www.mrcy.com ), a leading provider of affordable, commercially developed, open sensor processing systems and services for critical commercial, defense and intelligence applications, reported operating results for its fourth quarter and fiscal 2014 which ended June 30, 2014.
Model N, Inc., (NYSE: MODN), the leading revenue management solutions
provider to the life science and technology industries, today announced
financial results for the third quarter of fiscal 2014, which ended June
East West Bancorp, Inc. (“East West” or the “Company”) (Nasdaq: EWBC),
parent company of East West Bank, the financial bridge between the
United States and Greater China, appointed Molly Campbell, Deputy
Executive Director of the Port of Los Angeles, to its Board of
NEW YORK (MarketWatch) -- Morgan Stanley (MS) revealed it has reduced second-quarter earnings per share by two cents to 92 cents a share, from 94 cents a share, due to increased legal settlements, in a regulatory filing on Tuesday.
mPower Technologies, Inc. ( http://mpowertech.com/ ),
the consumer products subsidiary of mPhase Technologies, Inc. (XDSL),
announced today that revenues grew by approximately 6% for the three
month period ended June 30, 2014 as compared to the prior three month
period ended March 31, 2014.
NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science
tools for translational research and developer of molecular diagnostic
products, today announced that it has received market approval from the
Australian Therapeutic Goods Administration (TGA), clearing the company
to market its Prosigna ™ Breast Cancer Prognostic Gene
Signature Assay for assessing a woman’s risk of distant recurrence of
National CineMedia, Inc. (NASDAQ: NCMI) (the Company), the managing
member and owner of 45.8% of National CineMedia, LLC (NCM LLC), the
operator of the largest in-theatre digital media network in North
America, today announced consolidated results for the fiscal second
quarter ended June 26, 2014.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.